Erasca Earnings
NASDAQ: ERASHealth CareBiotechnology: Pharmaceutical PreparationsUSD
16.03+0.57 (+3.69%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Erasca earnings summary
In its most recent report on Aug 11, 2026 (Q2 2026), ERAS posted EPS of $-0.14. Across the last 16 reports, ERAS shares moved an average of 6.0% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
ERAS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 11, 2026 | — | $-0.14 | — | -4.1% |
| May 11, 2026 | — | $-0.60 | — | +9.9% |
| Mar 12, 2026 | — | $-0.10 | — | +7.2% |
| Nov 12, 2025 | — | $-0.11 | — | +13.2% |
| Aug 12, 2025 | — | $-0.12 | — | -2.4% |
| May 13, 2025 | — | $-0.11 | — | -5.1% |
| Mar 20, 2025 | — | $-0.06 | — | -0.7% |
| Nov 12, 2024 | — | $-0.11 | — | +1.1% |
| Aug 12, 2024 | — | $-0.29 | — | -1.8% |
| May 8, 2024 | — | $-0.23 | — | +6.5% |
| Mar 27, 2024 | — | $-0.20 | — | +1.9% |
| Nov 9, 2023 | — | $-0.20 | — | +13.9% |
| Aug 10, 2023 | — | $-0.21 | — | -13.7% |
| May 15, 2023 | — | $-0.22 | — | +1.8% |
| Mar 23, 2023 | — | $-1.09 | — | +6.4% |
| Nov 9, 2022 | — | $-0.29 | — | -6.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.